Dr. Michael Mcburney
Vice President for Healthcare Outcomes Policy and
Oncology and Molecular Radiation Sciences
Farmacore Biotechnology
Norway
Biography
Dr. Michael McBurney, a pioneer in research at The Ottawa Hospital and the University of Ottawa, will step down from his role as Scientific Director of the hospital’s Cancer Therapeutics Program on June 30, 2017.
Research Interest
Thirty years ago, Dr. McBurney led the drive to build the first cancer research laboratory at The Ottawa Hospital, called the Centre for Cancer Therapeutics. That centre has now broadened into the Cancer Therapeutics Program, which includes more than 300 researchers working together to advance our understanding of cancer, develop new therapies and improve patient care.
